/
DCF Valuation
Base-case fair value
$14.37
Intrinsic $19.16 · 25% MOS
Current price: $25.92
Base-case summary
Our base-case DCF for Pfizer Inc (PFE) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $9.5B in trailing free cash flow, this produces an intrinsic value of $19.16 per share. A 25% safety margin gives a fair value of $14.37, suggesting the stock is currently 45% overvalued against the $25.92 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$9.5B
Cash & equivalents
$9.9B
Total debt
$64.4B
Shares outstanding
5.7B